These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27005571)

  • 1. Predicting multi-class responses to preoperative chemoradiotherapy in rectal cancer patients.
    Gim J; Cho YB; Hong HK; Kim HC; Yun SH; Wu HG; Jeong SY; Joung JG; Park T; Park WY; Lee WY
    Radiat Oncol; 2016 Mar; 11():50. PubMed ID: 27005571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.
    Kim IJ; Lim SB; Kang HC; Chang HJ; Ahn SA; Park HW; Jang SG; Park JH; Kim DY; Jung KH; Choi HS; Jeong SY; Sohn DK; Kim DW; Park JG
    Dis Colon Rectum; 2007 Sep; 50(9):1342-53. PubMed ID: 17665260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profile can predict pathological response to preoperative chemoradiotherapy in rectal cancer.
    Nishioka M; Shimada M; Kurita N; Iwata T; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T
    Cancer Genomics Proteomics; 2011; 8(2):87-92. PubMed ID: 21471518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients.
    Agostini M; Zangrando A; Pastrello C; D'Angelo E; Romano G; Giovannoni R; Giordan M; Maretto I; Bedin C; Zanon C; Digito M; Esposito G; Mescoli C; Lavitrano M; Rizzolio F; Jurisica I; Giordano A; Pucciarelli S; Nitti D
    Cancer Biol Ther; 2015; 16(8):1160-71. PubMed ID: 26023803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancer.
    Nakao T; Iwata T; Hotchi M; Yoshikawa K; Higashijima J; Nishi M; Takasu C; Eto S; Teraoku H; Shimada M
    Oncol Rep; 2015 Oct; 34(4):1961-7. PubMed ID: 26260776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer.
    Lopes-Ramos C; Koyama FC; Habr-Gama A; Salim AC; Bettoni F; Asprino PF; França GS; Gama-Rodrigues J; Parmigiani RB; Perez RO; Galante PA; Camargo AA
    Cancer Genet; 2015 Jun; 208(6):319-26. PubMed ID: 25963525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of response to preoperative chemoradiotherapy in rectal cancer by using reverse transcriptase polymerase chain reaction analysis of four genes.
    Watanabe T; Kobunai T; Akiyoshi T; Matsuda K; Ishihara S; Nozawa K
    Dis Colon Rectum; 2014 Jan; 57(1):23-31. PubMed ID: 24316942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    Oncol Rep; 2012 Sep; 28(3):855-61. PubMed ID: 22711167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling.
    Folkvord S; Flatmark K; Dueland S; de Wijn R; Grøholt KK; Hole KH; Nesland JM; Ruijtenbeek R; Boender PJ; Johansen M; Giercksky KE; Ree AH
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):555-62. PubMed ID: 20675069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Tong T; Sun Y; Gollub MJ; Peng W; Cai S; Zhang Z; Gu Y
    J Magn Reson Imaging; 2015 Sep; 42(3):673-80. PubMed ID: 25652254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer.
    Kim NK; Hur H
    Yonsei Med J; 2015 Nov; 56(6):1461-77. PubMed ID: 26446626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
    Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
    Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.
    Koyama FC; Lopes Ramos CM; Ledesma F; Alves VAF; Fernandes JM; Vailati BB; São Julião GP; Habr-Gama A; Gama-Rodrigues J; Perez RO; Camargo AA
    Br J Surg; 2018 Jan; 105(2):e192-e203. PubMed ID: 29341150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profile is associated with chemoradiation resistance in rectal cancer.
    Gantt GA; Chen Y; Dejulius K; Mace AG; Barnholtz-Sloan J; Kalady MF
    Colorectal Dis; 2014 Jan; 16(1):57-66. PubMed ID: 24034224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M
    Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multigene Model for Predicting Tumor Responsiveness After Preoperative Chemoradiotherapy for Rectal Cancer.
    Cho E; Park IJ; Yeom SS; Hong SM; Lee JB; Kim YW; Kim MJ; Lim HM; Lim SB; Yu CS; Kim JC
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):834-842. PubMed ID: 31419511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined strategy of SAGE and quantitative PCR Provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer.
    Casado E; García VM; Sánchez JJ; Blanco M; Maurel J; Feliu J; Fernández-Martos C; de Castro J; Castelo B; Belda-Iniesta C; Sereno M; Sánchez-Llamas B; Burgos E; García-Cabezas MÁ; Manceñido N; Miquel R; García-Olmo D; González-Barón M; Cejas P
    Clin Cancer Res; 2011 Jun; 17(12):4145-54. PubMed ID: 21467161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery.
    Kang CM; Lim SB; Hong SM; Yu CS; Hong YS; Kim TW; Park JH; Kim JH; Kim JC
    Colorectal Dis; 2016 Jan; 18(1):O10-6. PubMed ID: 26530997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy.
    Millino C; Maretto I; Pacchioni B; Digito M; De Paoli A; Canzonieri V; D'Angelo E; Agostini M; Rizzolio F; Giordano A; Barina A; Rajendran S; Esposito G; Lanfranchi G; Nitti D; Pucciarelli S
    J Cell Physiol; 2017 Feb; 232(2):426-435. PubMed ID: 27225591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.